Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 6 of 6 for “"Transcription factor LSF"”.

  1. Transcription factor LSF: a mitotic regulator in hepatocellular carcinoma cells

    … evolutionarily conserved, ubiquitously expressed transcription factor LSF is overexpressed in HCC, and its expression is positively correlated with disease severity. Certain small molecules, known as Factor Quinolinone Inhibitors (FQIs), specifically inhibit LSF DNA-binding activity, inhibit HCC …

    bu Repository record for Transcription factor LSF: a mitotic regulator in hepatocellular carcinoma cells (opens in a new tab)

  2. Mapping the YY1 and p65 binding sites on the transcription factor LSF

    Late SV40 factor (LSF) is a CP2 family transcription factor involved in cell cycle regulation. In liver cancer, LSF is an oncogene, in part due to its role in upregulation of osteopontin leading to increase tumor size. As a result, LSF is a potential target for drug discovery. LSF binds the p65 …

    bu Repository record for Mapping the YY1 and p65 binding sites on the transcription factor LSF (opens in a new tab)

  3. Transcription factor LSF: interactions with protein partners leading to epigenetic regulation and microtubule modifications

    Transcription factor LSF is an oncogene in Hepatocellular Carcinoma (HCC). HCC is the sixth most common cancer worldwide and the second highest cause of cancer-related death globally. LSF is overexpressed in human HCC cell lines, compared to normal hepatocytes, and expression levels show …

    bu Repository record for Transcription factor LSF: interactions with protein partners leading to epigenetic regulation and microtubule modifications (opens in a new tab)

  4. The anti-cancer compound, Factor Quinolinone Inhibitor 1, inhibits stable kinetochore-microtubule attachment during mitotic progression

    Factor Quinolinone Inhibitor 1 (FQI1), discovered as a small molecule inhibitor of the transcription factor LSF, causes cell death in many cancer cell lines and inhibits tumor growth in tumor xenografts and an endogenous hepatocellular carcinoma model in mice. Significantly, multiple animal studies …

    bu Repository record for The anti-cancer compound, Factor Quinolinone Inhibitor 1, inhibits stable kinetochore-microtubule attachment during mitotic progression (opens in a new tab)

  5. Development and application of carbon-carbon bond forming methodologies

    … of the first small molecule inhibitor of transcription factor LSF is discussed. The isoquinolinone scaffolds were modified from a medicinal chemistry standpoint to optimize the pharmacophore. Synthetic pathways, structure activity relationships and solubility characteristics of the …

    bu Repository record for Development and application of carbon-carbon bond forming methodologies (opens in a new tab) Embargoed until 2999-01-01

  6. Synthetic and electrochemical strategies for the preparation of modified nucleotides and anticancer small molecules

    A class of small molecule inhibitors of oncogenic transcription factor LSF were developed. These “Factor Quinolinone Inhibitors”, or FQIs, were optimized through SAR development to maximize potency. An asymmetric Friedel-Crafts reaction was developed to afford (S)-FQI-34, the more active enantiomer …

    bu Repository record for Synthetic and electrochemical strategies for the preparation of modified nucleotides and anticancer small molecules (opens in a new tab)